We are experiencing intermittent navigation issues with our website. Some of our navigation options are not appearing correctly. We are working to restore the situation quickly. Thank you for understanding.

We are experiencing intermittent navigation issues with our website. Some of our navigation options are not appearing correctly. We are working to restore the situation quickly. Thank you for understanding.
Logo - Business Development Bank of Canada - BDC
Conjuchem logo
Exited company

Conjuchem

Details
Region
Quebec
Industry sector
Medical/health
Investment year
1998
Fund
Healthcare Venture Fund
Learn more
About the company

ConjuChem creates novel, next-generation medicines using unique, long-acting therapeutic peptides. Underlying all ConjuChem compounds are bioconjugation platforms called Drug Affinity Complex (DACTM) and Preformed Conjugate-Drug Affinity Complex (PC-DACTM). When applied to a given peptide, DACTM and PC-DACTM can create new drugs with similar therapeutic activities but with significantly longer durations of activity and improved safety profiles.